Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AirPods vs. hearing aids: which helps you hear better in a crowd?

NCT ID NCT06840015

Symptom relief Sponsor: The University of Texas at Dallas Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times

Summary

This study tests whether Apple AirPods can help adults with mild-to-moderate hearing loss understand speech in noisy places. Twenty-four participants will compare AirPods, hearing aids, and wireless microphones in a single lab session. Researchers will measure how well people hear, how much effort it takes, and which device people prefer.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AirPod Pro (2nd and 3rd generation) as hearing assistive device
What this could lead to
If successful, this could show that AirPods are a cheaper, more accessible option for people with mild-to-moderate hearing loss to hear better in noisy settings.
What could go wrong
This is a small, early study with only 24 participants. Results may not apply to everyone, and AirPods are not medical-grade devices, so they may not work as well as hearing aids for all users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 60 years. * Fluent English speakers. * Mild-to-moderate hearing loss confirmed by a pure-tone hearing test (average hearing threshold screening 25 to 55 dB HL across octave frequencies from 250 to 8000 Hz). * Individuals with no prior hearing aid experience for a year. Exclusion Criteria: * Normal hearing. * Hearing loss worse than moderate. * Neurological, psychiatric, or ophthalmological conditions that might alter the pupil response. * Non-fluent English speakers. * Individuals with prior hearing aid experience more than a year.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing AIDS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hearing loss disorder presbycusis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hearing AIDS Hearing loss, adult-onset

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Callier Center for Communication Disorders

    RECRUITING

    Richardson, Texas, 75080, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.